Indications for Hysterectomy

Carlson, Karen J.; Nichols, David H.; Schiff, Isaac

doi:10.1056/nejm199303253281207

Cited by 270 publications

(19 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…27 While approximately 11% of these women will have surgical correction by age 80, 15 over half of this population will have surgery before age 60 years. 28 A notable portion of these surgeries will be hysterectomies, as 15% of hysterectomies in the United States are performed for POP 13 with the largest proportion in age younger than 60 years. 28 Thus, a high surgical treatment rate at a relatively young age is an important aspect of POP and emphasizes the need to maximize success rates to minimize future procedures for recurrence.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Supracervical Robotic-Assisted Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse

Benson¹,

Kramer²,

Wayment³

et al. 2010

JSLS

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…13 Pelvic organ prolapse is a common female problem with 30% of women 50 years to 89 years of age presenting with POP-related symptoms, and 11% of women undergoing a corrective procedure for POP by age 80. 14,15 These POP repair procedures are most commonly vaginal sacrospinous ligament fixation and abdominal sacrocolpopexy.…”

Section: Introductionmentioning

confidence: 99%

Supracervical Robotic-Assisted Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse

Benson¹,

Kramer²,

Wayment³

et al. 2010

JSLS

View full text Add to dashboard Cite

show abstract

“…2 Uterine leiomyomas are the leading cause of hysterectomy (also the most common treatment for this condition). 3, 4 Uterine leiomyomas have a three-fold increased relative risk and prevalence among African-American women. 5 …”

Section: Introductionmentioning

confidence: 99%

The impact of uterine leiomyomas: a national survey of affected women

Borah

Nicholson²,

Bradley

et al. 2013

American Journal of Obstetrics and Gynecology

233

173

View full text Add to dashboard Cite

Objectives To characterize the impact of uterine leiomyomas (fibroids) in a racially diverse sample of women in the United States. Study Design A total of 968 women (573 White, 268 African-American, 127 other races) aged 29–59 with self-reported symptomatic uterine leiomyomas participated in a national survey. We assessed diagnosis, information seeking, attitudes about fertility, impact on work, and treatment preferences. Frequencies and percentages were summarized. Chi-square test was used to compare age groups. Results Women waited an average of 3.6 years before seeking treatment for leiomyomas, and 41% saw two or more healthcare providers for diagnosis. Almost a third of employed respondents (28%) reported missing work due to leiomyoma symptoms, and 24% felt that their symptoms prevented them from reaching their career potential. Women expressed desire for treatments that do not involve invasive surgery (79%), preserve the uterus (51%), and preserve fertility (43% of women under 40). Conclusions Uterine leiomyomas cause significant morbidity. When considering treatment, women are most concerned about surgical options, especially women under 40 who want to preserve fertility.

show abstract

“…However, hysterectomy is not accepted by women who have a strong desire for a future pregnancy. Therefore, nonsurgical treatment is the only available option for those women who want their uterus preserved [3,4]. …”

Section: Introductionmentioning

confidence: 99%

High-Intensity Focused Ultrasound (HIFU) in Uterine Fibroid Treatment: Review Study

et al. 2014

View full text Add to dashboard Cite

SummaryBackgroundHigh-intensity focused ultrasound (HIFU) is a highly precise medical procedure used locally to heat and destroy diseased tissue through ablation. This study intended to review HIFU in uterine fibroid therapy, to evaluate the role of HIFU in the therapy of leiomyomas as well as to review the actual clinical activities in this field including efficacy and safety measures beside the published clinical literature.Material/MethodsAn inclusive literature review was carried out in order to review the scientific foundation, and how it resulted in the development of extracorporeal distinct devices. Studies addressing HIFU in leiomyomas were identified from a search of the Internet scientific databases. The analysis of literature was limited to journal articles written in English and published between 2000 and 2013.ResultsIn current gynecologic oncology, HIFU is used clinically in the treatment of leiomyomas. Clinical research on HIFU therapy for leiomyomas began in the 1990s, and the majority of patients with leiomyomas were treated predominantly with HIFUNIT 9000 and prototype single focus ultrasound devices. HIFU is a non-invasive and highly effective standard treatment with a large indication range for all sizes of leiomyomas, associated with high efficacy, low operative morbidity and no systemic side effects.ConclusionsUterine fibroid treatment using HIFU was effective and safe in treating symptomatic uterine fibroids. Few studies are available in the literature regarding uterine artery embolization (UAE). HIFU provides an excellent option to treat uterine fibroids.

show abstract

Indications for Hysterectomy

Cited by 270 publications

References 38 publications

Supracervical Robotic-Assisted Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse

Supracervical Robotic-Assisted Laparoscopic Sacrocolpopexy for Pelvic Organ Prolapse

The impact of uterine leiomyomas: a national survey of affected women

High-Intensity Focused Ultrasound (HIFU) in Uterine Fibroid Treatment: Review Study

Contact Info

Product

Resources

About